title: [Efficacy and safety of selective estrogen receptor modulators in patients with advanced chronic kidney disease].
abstract: Selective estrogen receptor modulators(SERMs)have beneficial effects on the improvement of bone mineral density of the spine and hip, and decrease the vertebral fracture in postmenopausal women. Similar to patients with advanced chronic kidney disease, including dialysis patients, however, SERMs cannot decrease the risk of hip fracture, which is extremely high in Japanese dialysis patients. One of the most important disadvantages of SERMs is an increase in the risk of venous thromboembolic events and fatal stroke in high-risk groups of the Framingham Stroke Risk Score. On the other hand, SERMs may be used in unique osteoporosis drugs for reducing the incidence and progression of breast cancer. Moreover, SERMs attenuate oxidative stress and may lessen the deterioration of kidney function in patients with chronic kidney disease. The evidences for the efficacy and safety of SERMs in patients with advanced chronic kidney disease are insufficient, and knowledge concerning the selection and indication of osteoporosis drugs for those patients need to be developed.
authors: Department of Nephrology and Kidney Center, Kakogawa Central City Hospital, Division of Nephrology and Kidney Center, Kobe University Graduate School of Medicine, Japan.
authors: Kentaro
authors: K
authors: Nakai
mesh_terms: D000818:Animals; D015519:Bone Density / Q000187:drug effects; D001847:Bone Diseases / Q000188:drug therapy* / Q000209:etiology; D003404:Creatinine / Q000097:blood; D006801:Humans; D051436:Renal Insufficiency, Chronic / Q000150:complications*; D020845:Selective Estrogen Receptor Modulators / Q000009:adverse effects / Q000627:therapeutic use*
chemical_list: D020845:Selective Estrogen Receptor Modulators; D003404:Creatinine